Archives for 


Regulators Highlight Differing International Biosimilar Regulations; Interchangeability Guidance May Slip to 2017

Biosimilar News  •  BPCIA and Related U.S. Statutes  •  Interchangeability  •  Regulatory Guidances
Bloomberg BNA reported that a panel of regulators at the DIA 2016 Biosimilar Conference in Washington highlighted the differences among biosimilar regulations internationally and the ongoing changes as countries revise their biosimilar guidances. For […]

View More